These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6785815)

  • 1. Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine.
    Serra G; Argiolas A; Fadda F; Melis MR; Gessa GL
    Psychopharmacology (Berl); 1981; 73(2):194-6. PubMed ID: 6785815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock.
    Creese I; Kuczenski R; Segal D
    Pharmacol Biochem Behav; 1982 Aug; 17(2):375-6. PubMed ID: 6291070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Psychopharmacology (Berl); 1991; 105(2):230-8. PubMed ID: 1724565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of single and repeated electroconvulsive shock (ECS) on locomotor activity in rats.
    Ehlers CL; Indik JH; Koob GF; Bloom FE
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):217-22. PubMed ID: 6684316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.
    Spyraki C; Papadopoulou Z; Kourkoubas A; Varonos D
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):128-34. PubMed ID: 4040217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A; Srimal RC; Dhawan KN; Dhawan BN
    Neuropharmacology; 1987 Dec; 26(12):1733-7. PubMed ID: 3437939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
    Wielosz M; Szymczyk H
    Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of electroconvulsive shock on the discriminative stimulus properties of d-amphetamine and apomorphine: evidence for dopamine receptor alteration subsequent ECS.
    White DK; Barrett RJ
    Psychopharmacology (Berl); 1981; 73(3):211-4. PubMed ID: 6787638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.
    Modigh K
    J Neural Transm; 1975; 36(1):19-32. PubMed ID: 164522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated low dose apomorphine induced subsensitivity of presynaptic dopamine receptors.
    Masuda Y; Murai S; Saito H; Kohori I; Itoh T
    Pharmacol Biochem Behav; 1987 Sep; 28(1):35-7. PubMed ID: 3659103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.
    Green AR; Heal DJ; Johnson P; Laurence BE; Nimgaonkar VL
    Br J Pharmacol; 1983 Oct; 80(2):377-85. PubMed ID: 6606460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.
    Nomikos GG; Mathé AA; Mathé JM; Svensson TH
    Psychopharmacology (Berl); 1992; 108(3):367-70. PubMed ID: 1387964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSP-4 lesioning prevents the enhancement of dopamine and 5-hydroxytryptamine mediated behavioural changes by repeated electroconvulsive shock.
    Heal DJ; Davies CL; Goodwin GM
    Eur J Pharmacol; 1985 Sep; 115(1):117-21. PubMed ID: 4043230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy.
    Green AR; Johnson P; Mountford JA; Nimgaonkar VL
    Br J Pharmacol; 1985 Feb; 84(2):337-46. PubMed ID: 2983809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour.
    Green AR; Deakin JF
    Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks.
    Nutt DJ; Smith SL; Heal DJ
    Neuropharmacology; 1982 Sep; 21(9):881-4. PubMed ID: 7145040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High but not low ECS stimulus intensity augments apomorphine-stimulated dopamine postsynaptic receptor functioning in rats.
    Andrade C; Srinivasamurthy GM; Vishwasenani A; Prakash GS; Srihari BS; Chandra JS
    J ECT; 2002 Jun; 18(2):80-3. PubMed ID: 12195135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsensitivity of catecholaminergic neurons to direct acting agonists after single or repeated electroconvulsive shock.
    Tepper JM; Nakamura S; Spanis CW; Squire LR; Young SJ; Groves PM
    Biol Psychiatry; 1982 Oct; 17(10):1059-70. PubMed ID: 6293593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors.
    Smith SE; Sharp T
    Psychopharmacology (Berl); 1997 Sep; 133(1):77-84. PubMed ID: 9335084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.